One of the most unloved stocks on the ASX John but management don't appear to be the most proactive in terms of communicationThey are good with projects and deals though
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025